#National Alliance of State and Territorial AIDS Directors

During the COVID-19 crisis, some insurers are relaxing their refill rules and allowing 90-day supplies of meds to be prescribed.

Should you worry about your supply? Plus: Vice President Pence and AIDS expert Deborah Birx lead the U.S. coronavirus response.

As sexually transmitted infections spike to all-time highs, these 17 advocacy groups join forces to reverse the trend.

The nonprofit represents health officials who oversee HIV and hepatitis programs in the United States and across the globe.

HIV advocate Murray Penner describes how the Undetectable Equals Untransmittable message affected his journey living with the virus.

Only one company will sell a version of the HIV prevention pill Truvada. When others go to market, prices will likely drop further.

A statement from the Partnership to End HIV, STDs and Hepatitis

The proposal calls for new funds to end HIV in the U.S. But it also seeks massive cuts to domestic and global HIV programs.

A growing global community builds a movement.

The tool kit walks health departments through the process of coordinating care step-by-step.

The CDC is beginning to use molecular surveillance of HIV to identify transmission clusters, which has some privacy advocates concerned.

The executive director of the National Alliance of State and Territorial AIDS Directors (NASTAD) responds to comments by a Georgia lawmaker.

Read the joint statement addressing a Georgia lawmaker’s “extremely painful” comments.

As lawmakers postpone their vote, advocates and health groups respond to the bill that guts Medicaid. Here’s what they’re saying.

AIDS groups spell out how the proposed massive budget cuts will harm both local and global funding.

Check out these infographics that are part of NASTAD’s annual report.